GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

MedMira MIR.V · CAD

Health Care · TSX Venture · 🇨🇦 Canada

Compare

0.05

0.00%

Close of 6 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CAD, from our data supplier.

FY2025

Revenue

C$240,509

FY2016FY2025

Net income

−C$4.5m

FY2016FY2025

Free cash flow

−C$3.2m

FY2016FY2025

Shareholders' equity

−C$22.6m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueC$240,509C$412,568C$432,529C$952,127C$2.1mC$919,072C$527,445C$588,871C$747,344C$2.3m
Research and developmentC$1.3mC$476,891C$470,683C$191,138C$359,316C$199,269C$317,349C$522,940C$292,299C$2.5m
Operating income−C$3.4m−C$2.4m−C$1.9m−C$1.5m−C$184,232−C$1.3m−C$1.3m−C$1.8m−C$2.1m−C$4.5m
Net income−C$4.5m−C$3.3m−C$2.7m−C$1.8m−C$675,797−C$2.0m−C$2.1m−C$2.5m−C$2.7m−C$5.2m
Diluted earnings per share-0.01-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.01

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsC$3.7mC$6.1mC$3.7mC$3.8mC$3.9mC$3.4mC$252,518C$300,912C$673,705C$869,905
Cash and short-term investments——C$13,178C$33,461−C$2.3mC$401,861C$88,897—C$155,915C$46,120
Total liabilitiesC$26.2mC$24.1mC$18.7mC$16.2mC$19.6mC$19.0mC$13.8mC$11.7mC$9.7mC$8.5m
DebtC$2.0mC$891,783C$9.3mC$8.3mC$11.5mC$11.9mC$8.6mC$7.6mC$6.9mC$6.2m
Shareholders' equity−C$22.6m−C$18.0m−C$15.0m−C$12.4m−C$15.7m−C$15.6m−C$13.5m−C$11.4m−C$9.0m−C$7.7m
Shares outstanding698m698m697m697m661m658m658m658m658m658m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−C$3.1m−C$2.9m−C$1.3m−C$1.9m−C$504,639−C$315,896−C$941,131−C$795,406−C$1.9m−C$4.1m
Capital spending−C$7,468−C$742,535−C$1,267−C$69,717−C$36,547−C$101,882−C$101,882−C$3,342−C$3,342−C$27,249
Free cash flow−C$3.2m−C$3.7m−C$1.3m−C$2.0m−C$541,186−C$417,778−C$1.0m−C$798,748−C$1.9m−C$4.1m

Latest quarters

By quarter end

Apr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024Jul 2024
RevenueC$241,189C$24,503C$54,208C$50,668C$59,117C$69,001C$61,723C$64,462
Operating income−C$264,809−C$405,048−C$592,822−C$705,639−C$729,765−C$954,944−C$1.1m−C$860,570
Net income−C$483,660−C$657,552−C$813,134−C$1.0m−C$983,440−C$1.2m−C$1.3m−C$1.2m
Diluted earnings per share-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00
Total assetsC$3.4mC$3.6mC$3.6mC$3.7mC$3.8mC$4.2mC$5.0mC$6.1m
DebtC$454,323C$2.1mC$298,156C$2.0mC$1.5mC$752,670C$757,985C$891,783
Shareholders' equity−C$24.5m−C$24.0m−C$23.4m−C$22.6m−C$21.5m−C$20.5m−C$19.3m−C$18.0m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-36.8%-23.5%-24.6%
Operating income33.4%21.5%3.4%
Net income35.2%17.2%3.4%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-900.2%-455.2%-210.9%-173.1%
Net margin-1202.1%-606.5%-295.6%-231.6%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-10.0-19.9-28.7-30.5-195.7-78.9-1.8-0.2-0.2-0.1
Price to sales188.6160.7177.458.661.7175.57.10.80.80.3

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.